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Summary
 
Epidemiologic investigations have shown that exercise reduces morbidity and mortality from
coronary artery disease. In this study, using a rat model, we attempted to determine whether
exercise can reduce ischemic injury to the heart and elucidate a mechanism for the cardiopro-
tective effect of exercise. Results showed that exercise significantly reduced the magnitude of a
myocardial infarction in biphasic manner. The time course for cardioprotection resembled that
of the change in manganese superoxide dismutase (Mn-SOD) activity. The administration of
the antisense oligodeoxyribonucleotide to Mn-SOD abolished the expected decrease in infarct
size. We showed that the level of tumor necrosis factor 
 
a
 
 (TNF-
 
a
 
) and interleukin 1
 
b
 
 (IL-1
 
b
 
)
increased after exercise. The simultaneous administration of the neutralizing antibodies to the
cytokines abolished the exercise-induced cardioprotection and the activation of Mn-SOD.
Furthermore, TNF-
 
a
 
 can mimic the biphasic pattern of cardioprotection and activation of
Mn-SOD. An antioxidant completely abolished cardioprotection and the activation of Mn-
SOD by exercise or the injection of TNF-
 
a
 
 as well as exercise-induced increase in TNF-
 
a
 
 and
IL-1
 
b
 
. The production of reactive oxygen species and endogenous TNF-
 
a
 
 and IL-1
 
b
 
 induced
by exercise leads to the activation of Mn-SOD, which plays major roles in the acquisition of
biphasic cardioprotection against ischemia/reperfusion injury in rats.
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pidemiologic evidence demonstrates that regular phys-
ical exercise is associated with a reduced incidence of
coronary artery disease (CAD).
 
1
 
 Exercise can reduce such
risk factors for CAD as hyperlipidemia, diabetes, obesity,
and, perhaps, hypertension. Well-designed clinical investi-
gations have demonstrated that exercise is an independent
cardioprotective factor, even in the presence of other risk
factors (1, 2). The mechanisms of this protective effect of
exercise are supposed to include anatomic and physiologic
changes in the coronary arteries, alterations in autonomic
tone, and other effects, which lead to an increase in coro-
nary vascular transport activity (3). However, the direct proof
that exercise has a beneficial effect on myocardial ischemia/
reperfusion injury has not yet been presented.
The preconditioning phenomenon, in which exposure
to brief sublethal ischemia increases the tolerance of the
heart to subsequent lethal ischemia, is acquired both soon
after and 24 h after preconditioning in a biphasic manner,
as reported by our group and other authors (4–7). The pre-
conditioning phenomenon reportedly can be related to the
production of reactive oxygen species (8–11). The induc-
tion of an intrinsic radical scavenger, manganese-superox-
ide dismutase (Mn-SOD), by a brief period of ischemia has
been suggested to cause the heart to become tolerant to
ischemia/reperfusion injury (12–14). TNF and IL-1 are both
reported to be involved in cardioprotection against ischemia/
reperfusion injury (15–17).
Exercise has been reported to result in increased free rad-
ical production in the heart and other tissues (18, 19). Cyto-
kines such as TNF and IL-1 are produced after exercise
(20). These cytokines induce Mn-SOD in myocardium (16,
17). Therefore, we can hypothesize that the acquisition of
cardioprotective effect by exercise and brief ischemia may
involve a common mechanism that functions through an
 
1
 
Abbreviations used in this paper:
 
 ANOVA, analysis of variance;
 
 
 
ASODN,
antisense oligodeoxyribonucleotide; CAD, coronary artery disease; LCA,
left coronary artery; MPG, 
 
N
 
-2-mercaptopropionyl glycine; TTC, tri-
phenyltetrazolium chloride; Mn-SOD, manganese superoxide dismutase;
SODN, sense oligodeoxyribonucleotide. 
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increase in Mn-SOD activity via the production of reactive
oxygen species and cytokines.
In this study, we examined (a) whether a single session of
exercise reduces the size of the myocardial infarct after re-
perfusion; (b) whether cardioprotection induced by exercise
may be related to the activation of an intrinsic radical scav-
enger, Mn-SOD; (c) whether proinflammatory cytokines
TNF-
 
a
 
 and IL-1
 
b
 
 are involved in the activation of Mn-
SOD after exercise; and (d) whether a reactive oxygen spe-
cies–mediated mechanism is involved in the acquisition of
tolerance after exercise.
 
Materials and Methods
 
Exercise Protocol.
 
Male Wistar rats (weighing 240–300 g) were
initially screened by determining whether they could run on a
motor-driven treadmill at 20–25 m/min, 0% grade, for 20 min
(exercise began and ended with a 5-min “warm-up” and “cool-
down” at 15 m/min and 0% grade; the duration of exercise in-
cluded the warm-up and cool-down periods). At least 2 wk later,
only rats that completed the exercise screening test were used for
all experiments described in this study. For exercise experiments,
rats received one session of exercise, which consisted of running
on a treadmill at 27–30 m/min, 0% grade, for 25–30 min, includ-
ing the warm-up and cool-down periods as described for the
screening test. Rats in the sham-treated control group were
placed on the treadmill apparatus without exercise for 30 min and
allowed to recover at room temperature for a defined interval, as
indicated in the figure legends. Some rats were not placed on the
treadmill apparatus (untreated controls). After the exercise ses-
sion, rats were anesthetized with sodium pentobarbital, and the
chest of each rat was opened via a right parasternal sternomec-
tomy. The heart was exposed, and 7-0–type silk thread was then
passed around the left coronary artery (LCA) 3–4 mm distal to
the origin of LCA. After a 10-min period of stabilization, the
LCA was ligated. The snare was released after 20 min of coronary
occlusion. Reperfusion was indicated by a change in the color of
the ventricular surface. Arrhythmias were monitored by electro-
cardiogram. Ventricular fibrillation (VF) was defined according to
the criteria of the Lambeth Conventions (21). If VF occurred
during ischemia and did not resolve spontaneously within 3 s,
manual cardioversion was attempted by gentle palpation of the
nonischemic region of the heart. We excluded from infarct size
analysis rats in which VF persisted for more than 6 s or in which
cardioversion had to be performed 
 
.
 
3 times.
 
Measurement of Myocardial Infarct Size.
 
48 h after reperfusion,
the rats were killed by an overdose of sodium pentobarbital (100
mg/kg). The heart was excised and the size of the infarct was
evaluated by a method of double staining using Evans blue dye
and triphenyltetrazolium chloride (TTC) as previously described
(22, 23). The size of the myocardial infarct, i.e., the area without
TTC staining, was expressed as a percentage of the ischemic area
at risk, i.e., the area free of Evans blue dye.
The rate–pressure product showed no significant difference
among the groups before ischemia, at the end of the ischemic pe-
riod, or 30 min after reperfusion (data not shown).
 
SOD Activity and Content in Myocardium.
 
We measured the
activity and content of SODs, intrinsic radical scavengers that are
supposed to protect the heart against ischemia/reperfusion injury.
At the time after exercise indicated in the figures, rats in the exer-
cise and control groups were killed by administering an overdose
 
of sodium pentobarbital. The blood was washed out of the left
and right coronary arteries with PBS from the ascending aorta in
a retrograde manner. The left ventricular myocardium was rap-
idly frozen in liquid nitrogen and stored at 
 
2
 
80
 
8
 
C. SOD activity
of the myocardial samples was determined by the nitroblue tetra-
zolium method (24) with a modification for sample preparation
(23). Mn-SOD content was measured by means of an ELISA, as
we previously reported (12). The measurements of Mn-SOD ac-
tivity and content were performed at least in triplicate. The activ-
ity and content of Mn-SOD was corrected for the protein con-
centration in the supernatant determined according to the Lowry
method (24a).
 
TNF-
 
a
 
 and IL-1
 
b
 
 Levels in Myocardium.
 
To examine whether
TNF-
 
a
 
 and IL-1
 
b
 
 are involved in the activation of Mn-SOD af-
ter exercise, the levels of TNF-
 
a
 
 and IL-1
 
b
 
 in myocardium were
measured. Myocardium was homogenized in 20 mM PBS con-
taining 1 mM EDTA and centrifuged at 900 
 
g
 
 for 15 min. The
levels of TNF-
 
a
 
 and IL-1
 
b
 
 in the supernatant were measured by
means of ELISA kits (TNF-
 
a
 
, Genzyme Co.; IL-1
 
b
 
, Immuno-
Biological Labs. Co.). The measurements of cytokines were per-
formed in triplicate. The levels of TNF-
 
a
 
 and IL-1
 
b
 
 were cor-
rected for the protein concentration in the supernatant determined
by the Lowry method (24a).
 
Administration of Reagents.
 
To manipulate the level of expres-
sion of Mn-SOD, 22-mer phosphorothioate derivative of the
antisense oligodeoxyribonucleotide ([ASODN]; CACGCCGCCC-
GACACAACATTG), sense oligodeoxyribonucleotide ([SODN];
CAATGTTGTGTCGGGCGGCGTG), or scrambled ODN
(TCTCAGTGAGCCCTCATTCTGT) was injected intraperi-
toneally just after exercise at a dose of 10 mg/kg. To optimize the
experimental conditions for the in vivo delivery of systemically
injected ODNs, we evaluated the time course of their accumula-
tion in the heart. In experiments with 5
 
9
 
 FITC–labeled ASODN
to Mn-SOD, we found that significant labeling of these tissues
occurred at the following times after the intraperitoneal injection:
at 2–4 h in endothelial cells, at 4 h in vascular smooth muscle,
and at 8 h in cardiac myocytes (unpublished observation). We
could not determine the subcellular distribution of ASODN in
the cardiac myocytes due to technical limitations.
To neutralize the increases of TNF-
 
a
 
 and IL-1
 
b
 
 after exercise,
anti-murine TNF-
 
a
 
 antibody (0.5 ml) and/or anti-murine IL-1
 
b
 
antibody (0.5 mg), obtained from Genzyme, were infused intra-
peritoneally 30 min before exercise. Both antibodies cross-react
with rat cytokines.
Recombinant murine TNF-
 
a
 
 and recombinant murine IL-1
 
b
 
were obtained from Genzyme. The recombinant cytokines were
diluted in pathogen-free saline on the day of injection. Rats re-
ceived an intravenous injection of cytokine via the right femoral
vein for 2 min at a dose of 1.5 
 
m
 
g/kg body weight to examine
the involvement of TNF-
 
a
 
 in exercise-induced cardioprotection.
 
N
 
-2-mercaptopropionyl glycine (MPG) is a low molecular
weight, synthetic analogue of glutathione and a diffusible and
membrane-permeable antioxidant. This agent especially scav-
enges hydrogen peroxide and hydroxyl radicals. To determine
the involvement of reactive oxygen species during exercise in
the acquisition of tolerance against ischemia/reperfusion injury,
MPG (100 mg/kg) was infused intraperitoneally 10 min before
the 20-min exercise session or 30 min before the injection of
TNF-
 
a
 
. As the half-time for elimination of MPG is 
 
z
 
7 min
in vivo (25), MPG should not be effective during myocardial
ischemia/reperfusion period. Treatment with MPG also did not
alter the area at risk (data not shown), indicating that its effect on
infarct size may not be mediated via changes in collateral flow. 
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Statistical Methods.
 
Figure data are expressed as mean 
 
6 
 
SEM.
Intergroup comparisons were assessed for significance by using
one-way analysis of variance (ANOVA) with Bonferroni’s post
hoc test for multiple comparisons. A level of
 
 P 
 
, 
 
0.05 was ac-
cepted as statistically significant.
 
Results
 
Exclusion due to VF and Death.
 
A total of 28 rats devel-
oped serious VF during occlusion (10 in sham-treated con-
trol group, 4 in exercise group, 3 in AODN-treated group,
2 in exercise group treated with AODN, 2 in exercise group
pretreated with anti-murine TNF-
 
a
 
 and anti-murine IL-1
 
b
 
antibodies, 4 in TNF-
 
a
 
–treated group, 2 in exercise group
pretreated with MPG, and 1 in sham-treated control group
pretreated with MPG) and were excluded from the evalua-
tion of myocardial infarct size. 29 rats died prematurely
(probably because of arrhythmia or heart failure) during the
48-h reperfusion period (7 in sham-treated control group,
4 in exercise group, 3 in AODN-treated group, 1 in SODN-
treated group, 1 in exercise group treated with AODN, 1 in
exercise group treated with scrambled ODN, 1 in exercise
group pretreated with anti-murine TNF-
 
a
 
 antibody, 2 in
exercise group pretreated with anti-murine IL-1
 
b
 
 antibody,
2 in exercise group pretreated with anti-murine TNF-
 
a
 
and anti-murine IL-1
 
b
 
 antibodies, 5 in TNF-
 
a
 
–treated group,
1 in exercise group pretreated with MPG, and 1 in sham-
treated control group pretreated with MPG).
 
Size of Myocardial Infarct after Exercise.
 
We examined the
size of myocardial infarct after occlusion (20 min)/reperfu-
sion (48 h) in the LCA in rats, which received one session
of exercise. There were no significant differences in the size
of the myocardial infarct for recovery intervals of 0.5–72 h
among the sham-treated control groups (data not shown).
As shown in Fig. 1 (top), the size of the myocardial infarct
after reperfusion in the sham-treated control rats did not
differ significantly from the size of the infarct observed in
rats at 3, 24, and 72 h after exercise. However, rats sub-
jected to ischemia at 0.5, 36, 48, and 60 h after the exercise
session exhibited a marked decrease relative to the control
rats in the size of the myocardial infarct after reperfusion.
The infarct-limiting effect of exercise was slightly less at 36
and 60 h than at 0.5 and 48 h after exercise. The area at risk
did not differ significantly among the groups (data not shown).
 
Mn-SOD Activity after Exercise.
 
Reactive oxygen spe-
cies produced during ischemia/reperfusion in the heart
have been believed to induce myocardial cell damage (26–
28). An intrinsic radical scavenger, Mn-SOD protects hearts
against oxygen free radicals. To examine the involvement
of Mn-SOD in the cardioprotective effect of exercise, we
measured Mn-SOD activity after treadmill exercise. There
were no significant differences in the activity and content
of Mn-SOD for recovery intervals of 0.5–72 h among the
sham-treated control groups (data not shown). Mn-SOD
activity was unchanged at 3, 24, and 72 h after exercise but
was significantly increased at 0.5 and 48 h after exercise, as
compared with the sham-treated control (Fig. 1, center).
The biphasic time course of the change in Mn-SOD activ-
ity in the myocardium of rats exposed to exercise resem-
bled the time course for the protection against ischemia/
reperfusion injury. The myocardial content of Mn-SOD
did not change relative to the sham-treated control group
within 24 h after exercise. Thereafter, however, the Mn-
SOD level increased significantly, reaching 137% of the
control value 48 h after exercise (Fig. 1, bottom). The Mn-
SOD level returned to control values within 72 h after ex-
ercise. The activity of the cytosolic isoform of SOD (Cu,
Zn-SOD) was unaffected by exercise (data not shown).
We examined the relationship between the acquisition
of tolerance to ischemia/reperfusion and the induction of
Mn-SOD in the myocardium 48 h after exercise. We ma-
Figure 1.  Effect of exercise on the size of the myocardial infarct (top)
and the activity (center) and content (bottom) of Mn-SOD. Rats were
subjected to occlusion of the LCA followed by reperfusion at 0.5, 3, 24,
36, 48, 60, and 72 h after exercise. C, sham-treated control 0.5 h after
sham treatment. Top, the size of the infarct was evaluated 48 h after re-
perfusion. The size of the area of myocardial infarct (the area without TTC
staining) was expressed as a percentage of the ischemic area at risk (the
area without Evans blue dye); n 5 9–10. Center, Mn-SOD activity in the
myocardial tissue was examined between 0.5 and 72 h after one session of
exercise. Mn-SOD activity divided by total protein content is shown; n 5
3–4. Bottom, Mn-SOD content in myocardial tissue was examined be-
tween 0.5 and 72 h after one trial of exercise. Mn-SOD content divided
by total protein content is shown; n 5 3–4. Data are expressed as mean 6
SEM; *P , 0.05 vs. sham-treated control by one-way ANOVA with
Bonferroni’s post hoc test for multiple comparisons. 
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nipulated the level of expression of Mn-SOD using
ASODN. The administration of ASODN completely in-
hibited the increases in Mn-SOD activity and content 48 h
after exercise (Fig. 2, center and bottom). However, SODN
did not attenuate the increases in Mn-SOD activity and
content induced by exercise. As shown in Fig. 2 (top), the
expected decrease in infarct size induced by exercise was
also abolished in rats treated with ASODN to Mn-SOD, in
which the induction of Mn-SOD was specifically inhibited.
SODN, which did not attenuate the induction of Mn-SOD
in the myocardium after exercise, did not abolish the pro-
tective effect of exercise. Administration of the scrambled
oligonucleotide had no effect on infarct size or on Mn-SOD
activity as seen with SODN. Administration of ASODN
decreased the activity and content of Mn-SOD and in-
creased the infarct size after reperfusion in sham-treated
control rats.
 
Induction of Cardioprotection by Cytokines.
 
To examine the
contribution of the cytokines to exercise-induced cardio-
protection, we investigated the time course of the induc-
tion of TNF-
 
a
 
 and IL-1
 
b
 
 in the myocardium after exercise
using the ELISA method. There were no significant differ-
ences in TNF-
 
a
 
 and IL-1
 
b
 
 contents for recovery intervals
of 0–30 min among the sham-treated control groups (data
not shown). As illustrated in Fig. 3 (top), an increase in
TNF-
 
a
 
 content was evident immediately after exercise.
The level of TNF-
 
a
 
 peaked 10 min after exercise and then
decreased rapidly toward the baseline within 20 min. Im-
mediately after exercise, the myocardial level of IL-1
 
b
 
 also
increased significantly, as compared with the sham-treated
control group, and declined to the control level within 10
min (Fig. 3, bottom).
To determine whether the production of these cytokines
after exercise may be involved in the acquisition of toler-
ance to ischemia/reperfusion, we administered the anti-
body to these cytokines intraperitoneally 30 min before ex-
ercise. The intraperitoneal administration of anti-murine
TNF-
 
a
 
 and anti-murine IL-1
 
b
 
 antibody 30 min before ex-
ercise inhibited the observed increase in levels of TNF-
 
a
 
and IL-1
 
b
 
, respectively, after exercise (Fig. 3). As shown in
Fig. 4 (top), the administration of an antibody to TNF-
 
a
 
did not influence the size of infarct at 0.5 or 48 h after ex-
ercise. The administration of an antibody to IL-1
 
b
 
 also did
not alter the size of the myocardial infarct at 0.5 or 48 h af-
ter exercise. However, the simultaneous administration of
the antibodies to TNF-
 
a
 
 and IL-1
 
b
 
 abolished the protec-
tion against ischemic damage at 0.5 and 48 h after exercise.
Antibody to TNF-
 
a
 
 or IL-1
 
b
 
 had no effect on the increase
Figure 2.  Effects of ASODN to Mn-SOD on the size of the myocar-
dial infarct (top) and the activity (center) and content (bottom) of Mn-
SOD. SODN, ASODN, or scrambled ODN to Mn-SOD were injected
intraperitoneally into rats just after exercise (EX). In 48 h, rats were sub-
jected to occlusion of the LCA for 20 min, followed by reperfusion for 48 h.
The size of the myocardial infarct was measured after reperfusion (n 5
6–10). The activity and content of Mn-SOD (n 5 4–5) was evaluated 48 h
after exercise. C 48h, sham-treated control 48 h after sham treatment.
Data are expressed as mean 6 SEM; *P , 0.05 vs. sham-treated control;
1P , 0.05 vs. without ASODN by one-way ANOVA with the Bonfer-
roni’s post hoc test for multiple comparisons.
Figure 3.  Time course of myocardial levels of TNF-a (top) and IL-1b
(bottom) after exercise. After exercise, the myocardial levels of TNF-a
and IL-1b were measured with an ELISA (s). Increases in TNF-a and
IL-1b were neutralized by their respective antibodies (d). MPG abol-
ished the increases in TNF-a and IL-1b related to exercise (j). C, sham-
treated control just after sham treatment. Data are expressed as mean 6
SEM; n 5 3–4. *P , 0.05 vs. sham-treated control (C); 1P , 0.05 vs.
without antibody or MPG by one-way ANOVA with Bonferroni’s post
hoc test for multiple comparisons.1703 Yamashita et al.
in Mn-SOD activity induced by exercise (Fig. 4, bottom).
The simultaneous administration of the antibodies to these
cytokines eliminated the activation of Mn-SOD at 0.5 and
48 h after exercise.
We next investigated whether TNF-a could mimic
biphasic cardioprotection. In the untreated control groups,
the size of myocardial infarct and Mn-SOD activity re-
mained constant after vehicle (saline) injection in the time
course of the experiment (data not shown). As shown in
Fig. 5 (top), the infusion of murine rTNF-a reduced the
size of the infarct in a biphasic pattern. The first phase of
protection occurred 0.5 h after the administration of TNF-a.
When such tolerance had disappeared, the second phase of
protection was observed. Peak protection during the sec-
ond phase was achieved 48 h after administration of a bolus
injection of TNF-a. The time course was identical to that
for the cardioprotection induced by exercise (Fig. 1, top).
IL-1b also mimicked this biphasic cardioprotective effect
(data not shown).
The activity of Mn-SOD increased significantly in a bi-
phasic manner 48 as well as 0.5 h after the bolus injection
of TNF-a (Fig. 5, bottom). No change in Mn-SOD activ-
ity was observed 3, 24, and 72 h after TNF-a administra-
tion. IL-1b also activated Mn-SOD in a biphasic manner
(data not shown). The time course of cardioprotection co-
incided with that for the increase of Mn-SOD activity after
the administration of TNF-a. 
Involvement of Reactive Oxygen Species. To determine
whether the generation of reactive oxygen species during
exercise may be involved in the acquisition of tolerance to
ischemia/reperfusion, we administered an antioxidant, MPG,
10 min before exercise. Although this agent did not alter
the size of the myocardial infarct in the sham-treated con-
trol rats, MPG completely abolished the protection against
ischemia/reperfusion injury at 0.5 and 48 h after exercise
(Fig. 6, top).
MPG did not alter Mn-SOD activity in sham-treated
control rats, whereas it completely abolished the early (0.5-h)
Figure 4. Effects of anti–TNF-a and anti–IL-1b anti-
bodies on infarct size (top) and Mn-SOD activity (bot-
tom). Anti-murine TNF-a and/or anti-murine IL-1b an-
tibodies were infused intraperitoneally 30 min before
exercise. 0.5 or 48 h after exercise (EX), rats were sub-
jected to occlusion of the LCA followed by reperfusion.
C 0.5h and C 48h indicate sham-treated control 0.5 and
48 h after sham treatment, respectively. The size of the
myocardial infarct was measured 48 h after reperfusion (n 5
6–10). The activity of Mn-SOD (n 5 4–5) was evaluated
0.5 or 48 h after exercise. Data are expressed as mean 6
SEM; *P , 0.05 vs. corresponding sham-treated control;
1P , 0.05 vs. without the antibodies by one-way
ANOVA with Bonferroni’s post hoc test for multiple
comparisons.
Figure 5. Effects of TNF-a on size of myocardial infarct (top) and activ-
ity of Mn-SOD (bottom). After the intravenous injection of rTNF-a, rats
were subjected to LCA occlusion followed by reperfusion at the times indi-
cated. Infarct size was evaluated 48 h after reperfusion (n 5 7–9). The activ-
ity of Mn-SOD was measured at the indicated times after TNF-a adminis-
tration (n 5 4). C, untreated control 0.5 h after vehicle (saline) injection.
Data are expressed as mean 6 SEM; *P , 0.05 vs. control (C) by one-way
ANOVA with Bonferroni’s post hoc test for multiple comparisons.1704 Exercise-induced Cardioprotection
and late (48-h) peaks in Mn-SOD activity that followed
either exercise or the injection of TNF-a (Fig. 6, bottom).
MPG completely abolished the exercise-induced increase
in TNF-a and IL-1b in myocardial tissue (Fig. 3).
Discussion
Exercise Induces Cardioprotection. A substantial body of
epidemiologic evidence demonstrates that exercise reduces
cardiovascular mortality. Although exercise can improve
other known risk factors for CAD, such as elevated plasma
lipid level, obesity, and glucose intolerance, exercise ap-
pears to exert an independent cardioprotective effect (1, 2).
The present results provide the first demonstration that the
physiological stimulus of exercise has a directly beneficial
effect on myocardial ischemia/reperfusion injury in a bi-
phasic manner in an animal model. Exercise appears to in-
duce structural and/or functional adaptation, leading to an
increase in coronary vascular transport capacity (3). Bloor
et al. reported that exercise training could contribute to the
development of the collateral circulation and the tissue sal-
vage in the myocardial ischemia seen in pigs (29). How-
ever, we observed no difference in the area at risk among
the experimental groups, indicating that the beneficial ef-
fects of exercise are unlikely to be related to the develop-
ment of collateral circulation.
Involvement of Mn-SOD in Cardioprotection. The mech-
anism that underlies the cardioprotection observed at both
the early phase and the late phase after exercise appeared to
be related to an increase in Mn-SOD activity. A mecha-
nism remains to be elucidated for the activation of Mn-
SOD at the early phase (0.5 h) after exercise, where there
was no difference in Mn-SOD at the protein level between
the exercise and sham-treated control groups. These results
indicated that a precursor or inactive form of Mn-SOD
that possesses antigenicity but lacks enzyme activity may be
modulated by exercise. The increase of Mn-SOD activity
disappeared by 3 h after exercise, suggesting that a rapid in-
activation should follow the activation of Mn-SOD. It is
possible that a reversible phenomenon, such as a phosphor-
ylation–dephosphorylation mechanism, might be involved
in this step.
Inhibition of Mn-SOD induction at the late phase by the
administration of ASODN to Mn-SOD abolished the pro-
tection against ischemia/reperfusion injury induced by ex-
ercise. Therefore, at the late phase, the induction of Mn-
SOD leads to an increase in its enzyme activity, resulting in
the acquisition of cardioprotection against ischemia/reper-
fusion injury.
Signal Transduction for Cardioprotection. Previous reports
(20) and this study showed that TNF and IL-1 are pro-
duced after exercise. Our results clearly showed that TNF-a
and IL-1b are involved in exercise-induced cardiopro-
tection via activation of Mn-SOD. Because the effects of
TNF-a and IL-1b show some redundancy (30), either of
these cytokines is sufficient for both biphasic Mn-SOD ac-
tivation and cardioprotection, and the blockade of both cy-
tokines is necessary for the inhibition of Mn-SOD activa-
tion and cardioprotection induced by exercise. Although
the mechanism for the activation of Mn-SOD appears to
be different between early and late phases after exercise,
these cytokines can activate Mn-SOD at both phases.
It has been known that exercise produces reactive oxy-
gen species in the heart (18, 19). Our results indicated that
(i) reactive oxygen species induce TNF-a and IL-1b, (ii)
the activation of Mn-SOD by these cytokines is mediated
by the reactive oxygen species, and (iii) the cardioprotec-
tive effect of TNF-a administration is mediated through
the production of reactive oxygen species. Based on these
observations, we could elucidate the mechanism for the ex-
ercise-induced cardioprotection as follows. Reactive oxy-
gen species, produced during exercise, increase the levels of
TNF-a and IL-1b in myocardium. Then, the cytokines
activate Mn-SOD during the early phase and induce Mn-
SOD during the late phase of cardioprotection, possibly via
the production of reactive oxygen species. Reactive oxy-
gen species are present upstream as well as downstream of
the cytokines in the exercise-activated signaling pathway. It
is unclear whether the loop of these cytokines and reactive
oxygen species is necessary for the activation of Mn-SOD.
The production of reactive oxygen species by the cytokines
may take part in a positive feedback mechanism in this sig-
nal transduction system. The role of the reactive oxygen
species might be dose dependent. A high dose of reactive
Figure 6. Effects of MPG on size of infarct (top) and activity of Mn-
SOD (bottom). MPG was infused intraperitoneally 10 min before a 20-min
exercise period or 30 min before the injection of TNF-a. At 30 min and
48 h after exercise (EX) or the injection of TNF-a, rats were subjected to
occlusion of the LCA for 20 min, followed by reperfusion for 48 h. The size
of the infarct was then evaluated (n 5 7–9). The activity of Mn-SOD was
measured 0.5 and 48 h after exercise or the injection of TNF-a (n 5 4).
C 0.5h and C 48h indicate sham-treated control 0.5 and 48 h after sham
treatment, respectively. Both controls received vehicle (saline) injection.
There were no differences in the size of myocardial infarct or Mn-SOD
activity between the untreated and sham-treated control rats. Data are ex-
pressed as mean 6 SEM; *P , 0.05 vs. corresponding sham-treated con-
trol; 1P , 0.05. vs. without MPG by one-way ANOVA with Bonfer-
roni’s post hoc test for multiple comparisons.1705 Yamashita et al.
oxygen species causes damage to cardiac myocytes, whereas
a low dose of such species acts as a signal transduction mes-
senger in cells.
The transcriptional factors activator protein 1 and nu-
clear factor kB are subjected to redox regulation (31–36).
The activation of nuclear factor kB induces such cytokines
as TNF-a and IL-1b (37–39). TNF-a and IL-1b also stim-
ulate the production of reactive oxygen species in cells (40–
44). The induction of Mn-SOD is regulated under a redox
state (45) and is mediated by cytokines (46). Exercise may
activate these transcriptional factors via the production of
reactive oxygen species and lead to cytokine production.
However, the relationship between the activation of these
transcriptional factors and Mn-SOD as observed in the
early phase of cardioprotection remains to be established.
Cardioprotection by Sublethal Stress. The time course of
the cardioprotection induced by exercise resembles that
produced by a brief period of cardiac ischemia (ischemic
preconditioning) (4–7). This tolerance seems to be related
to the production of reactive oxygen species (8–11). The
induction of Mn-SOD by a brief period of ischemia is re-
sponsible for the preconditioning phenomenon (12–14).
TNF and IL-1 are both reported to be involved in cardio-
protection against ischemia/reperfusion injury (15–17) as
well as the radioresistance induced by sublethal ionizing ra-
diation or LPS (47). The sequence and nature of the signal
transduction steps in the preconditioning phenomenon and
radioresistance remain to be elucidated. The acquisition of
cardioprotection following sublethal stress such as brief
ischemia, exercise, ionizing radiation, and LPS may involve
a common mechanism that functions through an induction
and activation of Mn-SOD via the production of reactive
oxygen species and cytokines.
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